Product analysis
SAMe 200 mg supplies a compound used in normal metabolism, but a routine detox benefit remains uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The SAMe form is clearly named. A distinct quality or absorption advantage remains uncertain.
Ingredient Transparency100
The amount and form are both stated. That makes the supplement straightforward to identify and compare.
Value For Money40
The SAMe content offers limited value for the cost. Its unclear routine benefit makes that cost relevant when comparing options.
Customer Satisfaction74
Customer feedback is very positive, though based on a relatively modest number of ratings. That provides some context on satisfaction without establishing a liver or detox benefit.
Product Focus72
A single ingredient keeps the supplement narrowly focused. Its role in normal metabolism does not establish faster routine toxin clearance.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.66
- Customer rating
- 4.8 · 115 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
SAMe (S-Adenosyl-L-Methionine Disulfate Tosylate) | 200 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability77
Stabilized Salt Form
Packaging Integrity
Dose, Safety & Label Transparency60
Active Dosage Strength
Net SAMe Yield Transparency
Value40
Price Per 400mg Active Dose
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
- Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
- S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
- Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection.
- S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.